Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PBH
PBH logo

PBH News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PBH News

Three Companies for Steady Wealth Growth

3d agoFool

Doseology Sciences Launches New Energy Product Line

Feb 13 2026PRnewswire

Doseology Sciences Launches New Energy Product Line

Feb 13 2026Newsfilter

Prestige Consumer Healthcare Reports Q3 2026 Earnings with Strategic Insights

Feb 05 2026seekingalpha

Prestige (PBH) Q3 2026 Earnings Call Transcript

Feb 05 2026NASDAQ.COM

Prestige Consumer Healthcare Q3 Earnings Miss Expectations

Feb 05 2026seekingalpha

2026 Stock Market and Economic Forecast from Barron’s Roundtable Experts

Jan 09 2026Barron's

Prestige Consumer Acquires Pillar5 Pharma to Expand Eye Care Product Line

Jan 02 2026NASDAQ.COM

PBH Events

02/05 06:20
Clear Eyes Q3 Revenue at $283.4M, Below Consensus
Reports Q3 revenue $283.4M, consensus $286.52M. "We exceeded our third quarter revenue outlook and delivered solid profitability in the quarter, which reflected the benefits of our diverse business model and strong financial profile. We are pleased with these results, especially when navigating the challenging consumer backdrop we've experienced year-to-date. As expected, we continued to make progress toward improving Clear Eyes supply, increasing sales sequentially and closing on the acquisition of Pillar5 in December. Furthermore, our superior free cash flow and low leverage allowed us to repurchase approximately 0.8 million shares in the third quarter to further enhance shareholder value," said Ron Lombardi, CEO.
02/05 06:20
FY26 EPS Consensus at $4.56
FY26 EPS consensus $4.56. Narrows FY26 revenue growth view to (3.0%) from (3.0%)-(1.5%) from FY25 revenue of $1.14B, consensus $1.11B.

PBH Monitor News

No data

No data

PBH Earnings Analysis

No Data

No Data

People Also Watch